Laser therapy with
Newest Laser Hair Growth Helmet was evaluated as an effective method to stimulate hair growth. Hair loss is the most common problem in dermatology (especially in women). It causes significant psychosocial distress to patients, reduces quality of life, and has different types, but the most common types are androgenetic alopecia and telogen effluvium (TE).
Although there are many treatments with the highest level of medical evidence, patients who show intolerance or poor response to these treatments need additional treatment modalities.
To evaluate the efficacy and safety of laser therapy with the
Newest Laser Hair Growth Helmet for female pattern hair loss (FPHL) and TE. A prospective interventional study included 20 female patients, 13 of whom were diagnosed with FPHL and 7 with TE. Patients received the latest laser hair helmet treatment twice a week. Treatments lasted 20 minutes for 16 weeks (32 treatments in total) and were followed up.
Patients were evaluated by software analysis of trichoscope images, as the primary endpoint was the percentage increase in the number of hairs from baseline to post-treatment. Overall photography and patient satisfaction were determined as secondary endpoints. Twenty patients completed the study (13 FPHL, 7 TE). Baseline hair count was 222.3 ± 33.5 in FPHL patients (N = 13) and 271.2 ± 39.0 in TE patients (N = 7). Post-treatment hair count was 255.3 ± 30.4 in FPHL patients (N = 13) (P = .007) and 294.2 ± 38.1 in TE patients (N = 7) (P = .143). Scalp low-intensity laser treatment significantly improved hair count in FPHL and TE patients also had good improvements, with no serious adverse events.
